Cannabinoids in Bipolar Affective Disorder

NCT00397605 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped study was never started and no patients were ever enrolled

Conditions

Bipolar Affective Disorder

Interventions

DRUG: Synthetic cannabinoids (1:1 ratio of THC % CBD)

Sponsor

University of British Columbia

Collaborators

[object Object]